HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunophilin ligands FK506 and cyclosporine A improve neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits.

AbstractBACKGROUND:
We comparatively evaluated the protective effect of the immunophilin ligands cyclosporine A (INN: ciclosporin), FK506, and rapamycin on the spinal cord in a rabbit model of transient ischemia. Both cyclosporine A and FK506 inhibit calcineurin, whereas rapamycin does not.
METHODS:
Thirty-six male New Zealand White rabbits were divided into the following 6 groups: group C, 15 minutes of spinal cord ischemia; group FK, FK506 (1 mg/kg) administered 30 minutes before ischemia; group CsA, cyclosporine A (30 mg/kg) administered 30 minutes before ischemia; group CsA-C, chronic administration of cyclosporine A (20 mg/kg) for 9 days before ischemia; group R, rapamycin (1 mg/kg) administered 30 minutes before ischemia; and group R+FK, rapamycin (1 mg/kg) administered 20 minutes before FK506 pretreatment (1 mg/kg). Group CsA-C was added because the drug does not readily cross the blood-brain barrier. Neurologic function was evaluated by Johnson's 5-point scale at 8, 24, and 48 hours after ischemia, and histopathology was assessed 48 hours after ischemia.
RESULTS:
At 24 and 48 hours after ischemia, the Johnson score was better in groups FK (4.0 +/- 1.1), R+FK (3 +/- 1.1), and CsA-C (2.7 +/- 1.2) than in group C (0.8 +/- 1.2). Numbers of morphologically intact anterior horn cells were higher in groups FK (31.3 +/- 9.9), R+FK (23.2 +/- 4.5), and CsA-C (18.3 +/- 6.8) than in group C (6.3 +/- 4.3).
CONCLUSIONS:
FK506 and chronic administration of cyclosporine A, but not rapamycin, protect the spinal cord from transient ischemia. Although these results are compatible with inhibition of calcineurin in the mechanism of neuroprotective action of these drugs, other effects through different pathways cannot be excluded before further study.
AuthorsTsuyoshi Tachibana, Norihiko Shiiya, Takashi Kunihara, Yutaka Wakamatsu, Akimaro Fabio Kudo, Tomonori Ooka, Satoshi Watanabe, Keishu Yasuda
JournalThe Journal of thoracic and cardiovascular surgery (J Thorac Cardiovasc Surg) Vol. 129 Issue 1 Pg. 123-8 (Jan 2005) ISSN: 0022-5223 [Print] United States
PMID15632833 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Neuroprotective Agents
  • Cyclosporine
  • Sirolimus
  • Tacrolimus
Topics
  • Animals
  • Ataxia (diagnosis, epidemiology)
  • Biopsy, Needle
  • Cyclosporine (pharmacology)
  • Disease Models, Animal
  • Drug Interactions
  • Immunohistochemistry
  • Male
  • Neurologic Examination
  • Neuroprotective Agents (pharmacology)
  • Paralysis (diagnosis, epidemiology)
  • Paraparesis (diagnosis, epidemiology)
  • Probability
  • Rabbits
  • Random Allocation
  • Risk Factors
  • Sensitivity and Specificity
  • Sirolimus (pharmacology)
  • Spinal Cord Ischemia (drug therapy, pathology, physiopathology)
  • Statistics, Nonparametric
  • Tacrolimus (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: